Avstera Therapeutics
Avstera Therapeutics is a startup headquartered in Malvern, United States, founded in 2020. It has raised at least $5.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Avstera Therapeutics has raised at least $5.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Avstera Therapeutics sits inside the Philadelphia region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Malvern
Related
- Innovation profile of Malvern
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Avstera Therapeutics do?
Avstera Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Avstera Therapeutics raised?
At least $5.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Avstera Therapeutics based?
Avstera Therapeutics is headquartered in Malvern, United States.
When was Avstera Therapeutics founded?
Avstera Therapeutics was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.